In € million

 

Equity attributable to equity holders of the parent

 

 

 

 

 

Revaluation reserve
(fair value)

 

 

 
 

Notes

 

Share capital

 

Share pre­miums

 

Trea­sury shares

 

Perpet­ual hybrid bonds

 

Re­tained earn­ings

 

 

 

Cur­rency trans­lation differ­ences

 

Equity instru­ments mea­sured at FVOCI(1)

 

Cash flow hedges

 

Defined benefit pension plan

 

Total re­serves

 

Non-con­trolling inter­ests

 

Total equity

(1)

Label has been changed from “Available-for-sale financial assets” to “Equity instruments measured at fair value through other comprehensive income” following IFRS 9 application. Comparative figures are similar to those published in the 2017 Annual Report.

Balance at December 31, 2016

 

 

 

1,588

 

1,170

 

(274)

 

2,188

 

5,899

 

 

 

(39)

 

8

 

(5)

 

(828)

 

8,117

 

250

 

9,956

Profit for the year

 

 

 

 

 

 

 

 

 

 

 

1,061

 

 

 

 

 

 

 

 

 

 

 

1,061

 

56

 

1,116

Items of other comprehensive income

 

(F11)

 

 

 

 

 

 

 

 

 

0

 

 

 

(795)

 

(3)

 

22

 

128

 

(648)

 

(35)

 

(684)

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

1,061

 

 

 

(795)

 

(3)

 

22

 

128

 

412

 

20

 

433

Cost of stock options

 

 

 

 

 

 

 

 

 

 

 

10

 

 

 

 

 

 

 

 

 

 

 

10

 

 

 

10

Dividends

 

 

 

 

 

 

 

 

 

 

 

(363)

 

 

 

 

 

 

 

 

 

 

 

(363)

 

(41)

 

(404)

Coupons of perpetual hybrid bonds

 

 

 

 

 

 

 

 

 

 

 

(111)

 

 

 

 

 

 

 

 

 

 

 

(111)

 

 

 

(111)

Acquisition (–)/sale of treasury shares

 

 

 

 

 

 

 

(7)

 

 

 

(7)

 

 

 

 

 

 

 

 

 

 

 

(14)

 

 

 

(14)

Increase/decrease (–) through changes in ownership interests in subsidiaries that result in loss of control

 

 

 

 

 

 

 

 

 

 

 

(34)

 

 

 

 

 

 

 

0

 

34

 

1

 

(117)

 

(116)

Balance at December 31, 2017

 

 

 

1,588

 

1,170

 

(281)

 

2,188

 

6,454

 

 

 

(834)

 

5

 

16

 

(665)

 

8,051

 

113

 

9,752

IFRS 9 adoption

 

 

 

 

 

 

 

 

 

 

 

(5)

 

 

 

 

 

 

 

 

 

 

 

(5)

 

 

 

(5)

Balance at January 1, 2018

 

 

 

1,588

 

1,170

 

(281)

 

2,188

 

6,449

 

 

 

(834)

 

5

 

16

 

(665)

 

8,046

 

113

 

9,747

Profit for the year

 

 

 

 

 

 

 

 

 

 

 

858

 

 

 

 

 

 

 

 

 

 

 

858

 

39

 

897

Items of other comprehensive income

 

(F11)

 

 

 

 

 

 

 

 

 

0

 

 

 

217

 

4

 

(42)

 

22

 

200

 

4

 

204

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

858

 

 

 

217

 

4

 

(42)

 

22

 

1,058

 

43

 

1,101

Perpetual hybrid bonds issuance

 

(F31)

 

 

 

 

 

 

 

298

 

 

 

 

 

 

 

 

 

 

 

 

 

298

 

 

 

298

Cost of stock options

 

 

 

 

 

 

 

 

 

 

 

9

 

 

 

 

 

 

 

 

 

 

 

9

 

 

 

9

Dividends

 

 

 

 

 

 

 

 

 

 

 

(378)

 

 

 

 

 

 

 

 

 

 

 

(378)

 

(40)

 

(418)

Coupons of perpetual hybrid bonds

 

 

 

 

 

 

 

 

 

 

 

(111)

 

 

 

 

 

 

 

 

 

 

 

(111)

 

 

 

(111)

Acquisition (–)/sale of treasury shares

 

 

 

 

 

 

 

(18)

 

 

 

(4)

 

 

 

 

 

 

 

 

 

 

 

(22)

 

 

 

(22)

Other

 

 

 

 

 

 

 

 

 

 

 

11

 

 

 

 

 

 

 

0

 

8

 

19

 

1

 

19

Balance at December 31, 2018

 

 

 

1,588

 

1,170

 

(299)

 

2,486

 

6,834

 

 

 

(618)

 

9

 

(26)

 

(635)

 

8,920

 

117

 

10,624

In 2017 the € (117) million reduction in equity related mainly to non-controlling interest following the completion of the Emerging Biochemicals divestment.

In € million

 

Equity attributable to equity holders of the parent

 

 

 

 

 

Revaluation reserve
(fair value)

 

 

 
 

Notes

 

Share capital

 

Share pre­miums

 

Trea­sury shares

 

Perpet­ual hybrid bonds

 

Re­tained earn­ings

 

 

 

Cur­rency trans­lation differ­ences

 

Equity instru­ments mea­sured at FVOCI(1)

 

Cash flow hedges

 

Defined benefit pension plan

 

Total re­serves

 

Non-con­trolling inter­ests

 

Total equity

(1)

Label has been changed from “Available-for-sale financial assets” to “Equity instruments measured at fair value through other comprehensive income” following IFRS 9 application. Comparative figures are similar to those published in the 2017 Annual Report.

Balance at December 31, 2016

 

 

 

1,588

 

1,170

 

(274)

 

2,188

 

5,899

 

 

 

(39)

 

8

 

(5)

 

(828)

 

8,117

 

250

 

9,956

Profit for the year

 

 

 

 

 

 

 

 

 

 

 

1,061

 

 

 

 

 

 

 

 

 

 

 

1,061

 

56

 

1,116

Items of other comprehensive income

 

(F11)

 

 

 

 

 

 

 

 

 

0

 

 

 

(795)

 

(3)

 

22

 

128

 

(648)

 

(35)

 

(684)

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

1,061

 

 

 

(795)

 

(3)

 

22

 

128

 

412

 

20

 

433

Cost of stock options

 

 

 

 

 

 

 

 

 

 

 

10

 

 

 

 

 

 

 

 

 

 

 

10

 

 

 

10

Dividends

 

 

 

 

 

 

 

 

 

 

 

(363)

 

 

 

 

 

 

 

 

 

 

 

(363)

 

(41)

 

(404)

Coupons of perpetual hybrid bonds

 

 

 

 

 

 

 

 

 

 

 

(111)

 

 

 

 

 

 

 

 

 

 

 

(111)

 

 

 

(111)

Acquisition (–)/sale of treasury shares

 

 

 

 

 

 

 

(7)

 

 

 

(7)

 

 

 

 

 

 

 

 

 

 

 

(14)

 

 

 

(14)

Increase/decrease (–) through changes in ownership interests in subsidiaries that result in loss of control

 

 

 

 

 

 

 

 

 

 

 

(34)

 

 

 

 

 

 

 

0

 

34

 

1

 

(117)

 

(116)

Balance at December 31, 2017

 

 

 

1,588

 

1,170

 

(281)

 

2,188

 

6,454

 

 

 

(834)

 

5

 

16

 

(665)

 

8,051

 

113

 

9,752

IFRS 9 adoption

 

 

 

 

 

 

 

 

 

 

 

(5)

 

 

 

 

 

 

 

 

 

 

 

(5)

 

 

 

(5)

Balance at January 1, 2018

 

 

 

1,588

 

1,170

 

(281)

 

2,188

 

6,449

 

 

 

(834)

 

5

 

16

 

(665)

 

8,046

 

113

 

9,747

Profit for the year

 

 

 

 

 

 

 

 

 

 

 

858

 

 

 

 

 

 

 

 

 

 

 

858

 

39

 

897

Items of other comprehensive income

 

(F11)

 

 

 

 

 

 

 

 

 

0

 

 

 

217

 

4

 

(42)

 

22

 

200

 

4

 

204

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

858

 

 

 

217

 

4

 

(42)

 

22

 

1,058

 

43

 

1,101

Perpetual hybrid bonds issuance

 

(F31)

 

 

 

 

 

 

 

298

 

 

 

 

 

 

 

 

 

 

 

 

 

298

 

 

 

298

Cost of stock options

 

 

 

 

 

 

 

 

 

 

 

9

 

 

 

 

 

 

 

 

 

 

 

9

 

 

 

9

Dividends

 

 

 

 

 

 

 

 

 

 

 

(378)

 

 

 

 

 

 

 

 

 

 

 

(378)

 

(40)

 

(418)

Coupons of perpetual hybrid bonds

 

 

 

 

 

 

 

 

 

 

 

(111)

 

 

 

 

 

 

 

 

 

 

 

(111)

 

 

 

(111)

Acquisition (–)/sale of treasury shares

 

 

 

 

 

 

 

(18)

 

 

 

(4)

 

 

 

 

 

 

 

 

 

 

 

(22)

 

 

 

(22)

Other

 

 

 

 

 

 

 

 

 

 

 

11

 

 

 

 

 

 

 

0

 

8

 

19

 

1

 

19

Balance at December 31, 2018

 

 

 

1,588

 

1,170

 

(299)

 

2,486

 

6,834

 

 

 

(618)

 

9

 

(26)

 

(635)

 

8,920

 

117

 

10,624